Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Righini

Showing results (221-230 of 284) with videos related to

Pageof 29
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 11, 2022
Risk of neonatal hypothyroidism in newborns from mothers exposed to CTPA during pregnancy: Ancillary data from a prospective outcome studyMarc Righini, Helia Robert-Ebadi, Alessio Cremonesi, et al.
Haematologica|April 19, 2012
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excludedRenée A Douma, Melanie Tan, Roger E G Schutgens, et al.
Plos One|February 25, 2016
Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research StudyCharlène Insam, Marie Méan, Andreas Limacher, et al.
Journal of General Internal Medicine|August 22, 2014
Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismWaltraud Leiss, Marie Méan, Andreas Limacher, et al.
Research and Practice in Thrombosis and Haemostasis|September 10, 2024
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trialRiccardo M Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Blood Advances|November 29, 2018
American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolismWendy Lim, Grégoire Le Gal, Shannon M Bates, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position PaperBenilde Cosmi, Agata Stanek, Matja Kozak, et al.
Lancet (London, England)|April 22, 2008
Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trialMarc Righini, Grégoire Le Gal, Drahomir Aujesky, et al.
Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trialMarc Blondon, Sara Cereghetti, Jérôme Pugin, et al.
Pageof 29

Showing results (221-230 of 284) with videos related to

Sort By:
Pageof 29
Journal of Thrombosis and Haemostasis : JTH|August 11, 2022
Risk of neonatal hypothyroidism in newborns from mothers exposed to CTPA during pregnancy: Ancillary data from a prospective outcome studyMarc Righini, Helia Robert-Ebadi, Alessio Cremonesi, et al.
Haematologica|April 19, 2012
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excludedRenée A Douma, Melanie Tan, Roger E G Schutgens, et al.
Plos One|February 25, 2016
Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research StudyCharlène Insam, Marie Méan, Andreas Limacher, et al.
Journal of General Internal Medicine|August 22, 2014
Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismWaltraud Leiss, Marie Méan, Andreas Limacher, et al.
Research and Practice in Thrombosis and Haemostasis|September 10, 2024
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trialRiccardo M Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Blood Advances|November 29, 2018
American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolismWendy Lim, Grégoire Le Gal, Shannon M Bates, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position PaperBenilde Cosmi, Agata Stanek, Matja Kozak, et al.
Lancet (London, England)|April 22, 2008
Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trialMarc Righini, Grégoire Le Gal, Drahomir Aujesky, et al.
Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.
Research and Practice in Thrombosis and Haemostasis|May 23, 2022
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trialMarc Blondon, Sara Cereghetti, Jérôme Pugin, et al.
Pageof 29